Jerome Macapagal

A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients

M. Brimble, V. Hinder, I. Hermans, 2018, Cancer Immunology, Immunotherapy.

Methods of a national colorectal cancer cohort study: the PIPER Project.

S. Derrett, D. Sarfati, V. Hinder, 2016, The New Zealand medical journal.

A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma

Rajiv Kumar, M. Brimble, V. Hinder, 2023, Cancer Immunology, Immunotherapy.

Transient elevation in serum carcinoembryonic antigen while on adjuvant chemotherapy for colon cancer: Is this of prognostic importance?

V. Hinder, M. Findlay, K. Sharples, 2017, Asia-Pacific journal of clinical oncology.

The New Zealand PIPER Project: colorectal cancer survival according to rurality, ethnicity and socioeconomic deprivation-results from a retrospective cohort study.

S. Derrett, D. Sarfati, V. Hinder, 2018, The New Zealand medical journal.